Bruker completes acquisition of Oncovision's preclinical PET imaging business

Bruker has completed the acquisition of the preclinical PET imaging business of Oncovision. Financial terms were not disclosed.

“PET imaging is one of the most important imaging modalities for translational research.”prnewswire.com

• 1 source
• prnewswire.comBruker Completes Acquisition of Preclinical PET Imaging BusinessBruker CorporationNov 22, 2016

Summarized from public sources; check the original articles before acting on it.